Pharmaust - Media & News, page-171

Guess we all have different investment plans & strategies as the PAA story plays out over the next 18 months - 2 years.
Important thing is to plan !

For me, it goes something like this ( until the plan changes of course ! ).

1. News on MPL MoA and possible efficacy against other neurodegenerative conditions, plus Healey first recruitment ( and all the preceding news to this milestone ) should see the company approach a $500M MC, perhaps an initial sign-on deal from a mid-size / big Phrama. So, around $1.00 SP. I'll be taking around 20% off the table at this stage - enough for free carry and to invest in some other life pursuits.

2. The remainder - while the science remains compelling, I'd like to see it through to Healey results come in. If they are as positive as very early indications suggest - well then a $2.5B - $5.0B MC may well be representative of true value.

In the meantime, SP machinations remain background noise.

ALL IMO.
Definitely not financial advice